These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23140185)

  • 1. Atorvastatin calcium plus amlodipine for the treatment of hypertension.
    Delgado-Montero A; Zamorano JL
    Expert Opin Pharmacother; 2012 Dec; 13(18):2673-85. PubMed ID: 23140185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single-pill combination of amlodipine besylate and atorvastatin calcium.
    Blank R
    Drugs Today (Barc); 2006 Mar; 42(3):157-75. PubMed ID: 16628258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-pill amlodipine/atorvastatin helps patients of diverse ethnicity attain recommended goals for blood pressure and lipids (the Gemini-AALA study).
    Erdine S; Ro YM; Tse HF; Howes LG; Aguilar-Salinas CA; Chaves H; Guindy R; Chopra P; Moller RA; Schou IM;
    J Hum Hypertens; 2009 Mar; 23(3):196-210. PubMed ID: 18800143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, placebo-controlled trial to evaluate the efficacy, safety, and pharmacodynamic interaction of coadministered amlodipine and atorvastatin in 1660 patients with concomitant hypertension and dyslipidemia: the respond trial.
    Preston RA; Harvey P; Herfert O; Dykstra G; Jukema JW; Sun F; Gillen D
    J Clin Pharmacol; 2007 Dec; 47(12):1555-69. PubMed ID: 18048574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine/atorvastatin) to attain recommended target levels for blood pressure and lipids (The JEWEL Program).
    Hobbs FD; Gensini G; Mancini GB; Manolis AJ; Bauer B; Böhler S; Genest J; Feldman R; Harvey P; Jenssen TG; Metcalfe M; da Silva PM;
    Int J Cardiol; 2006 Jun; 110(2):242-50. PubMed ID: 16338012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fixed combination of amlodipine/atorvastatin: from mechanisms to trials.
    Ivanovic B; Tadic M
    J Cardiovasc Pharmacol Ther; 2013 Nov; 18(6):544-9. PubMed ID: 23832643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives.
    Devabhaktuni M; Bangalore S
    Vasc Health Risk Manag; 2009; 5(1):377-87. PubMed ID: 19475775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post hoc analysis of the Cluster Randomized Usual Care versus Caduet Investigation Assessing Long-term risk (CRUCIAL) trial.
    Hradec J; Zamorano J; Sutradhar S
    Curr Med Res Opin; 2013 Jun; 29(6):589-96. PubMed ID: 23464930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single-pill combination of amlodipine besylate and atorvastatin calcium (update).
    Blank R; Hobbs FD; Zamorano J; Girerd X
    Drugs Today (Barc); 2007 Mar; 43(3):157-77. PubMed ID: 17380213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction in cardiovascular risk using a proactive multifactorial intervention is consistent among patients residing in Pacific Asian and non-Pacific Asian regions: a CRUCIAL trial subanalysis.
    Cho EJ; Kim JH; Sutradhar S; Yunis C; Westergaard M;
    Vasc Health Risk Manag; 2014; 10():145-56. PubMed ID: 24707184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amlodipine/atorvastatin: the first cross risk factor polypill for the prevention and treatment of cardiovascular disease.
    Frishman WH; Zuckerman AL
    Expert Rev Cardiovasc Ther; 2004 Sep; 2(5):675-81. PubMed ID: 15350169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slovak trial on cardiovascular risk reduction following national guidelines with CaDUET® (the STRONG DUET study).
    Fedacko J; Pella D; Jarcuska P; Sabol F; Kmec J; Lopuchovsky T; Merkovska L; Jedlickova L; Janicko M; Sajty M
    Adv Ther; 2013 Jan; 30(1):60-70. PubMed ID: 23328937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea.
    Liew D; Park HJ; Ko SK
    Clin Ther; 2009 Oct; 31(10):2189-203; discussion 2150-1. PubMed ID: 19922890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amlodipine/atorvastatin fixed-dose combination: a review of its use in the prevention of cardiovascular disease and in the treatment of hypertension and dyslipidemia.
    McKeage K; Siddiqui MA
    Am J Cardiovasc Drugs; 2008; 8(1):51-67. PubMed ID: 18303938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of amlodipine plus atorvastatin association in hypertensive hypercholesterolemic patients.
    Derosa G; Maffioli P
    Expert Rev Cardiovasc Ther; 2010 Jun; 8(6):835-43. PubMed ID: 20528641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous treatment of hypertension and dyslipidaemia may help to reduce overall cardiovascular risk: focus on amlodipine/atorvastatin single-pill therapy.
    Cowie MR
    Int J Clin Pract; 2005 Jul; 59(7):839-46. PubMed ID: 15963213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amlodipine/Atorvastatin: a review of its use in the treatment of hypertension and dyslipidaemia and the prevention of cardiovascular disease.
    Curran MP
    Drugs; 2010; 70(2):191-213. PubMed ID: 20108992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atorvastatin and amlodipine: the successful duet that led to Caduet.
    Cardiovasc J Afr; 2009; 20(1):87-8. PubMed ID: 19287825
    [No Abstract]   [Full Text] [Related]  

  • 19. Simultaneous treatment to attain blood pressure and lipid goals and reduced CV risk burden using amlodipine/atorvastatin single-pill therapy in treated hypertensive participants in a randomized controlled trial.
    Grimm R; Malik M; Yunis C; Sutradhar S; Kursun A;
    Vasc Health Risk Manag; 2010 May; 6():261-71. PubMed ID: 20479948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in US managed care enrolees? A non-randomized, observational, retrospective study.
    Hussein MA; Chapman RH; Benner JS; Tang SS; Solomon HA; Joyce A; Foody JM
    Am J Cardiovasc Drugs; 2010; 10(3):193-202. PubMed ID: 20387911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.